Literature DB >> 10462280

Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease.

M Tozawa1, K Iseki, S Yoshi, K Fukiyama.   

Abstract

BACKGROUND: Prospective and case-control studies show that blood-pressure variability is an independent risk factor for severe organ damage and cardiovascular events in hypertensives. We prospectively studied the association between systolic blood pressure variability and cardiovascular mortality and mortality from all causes in end-stage renal disease patients. METHODS AND
RESULTS: The subjects were 144 patients (86 men, 58 women; mean age+/-SD, 52+/-13 years) who underwent dialysis in the same dialysis centre and were examined for blood-pressure variability. The study period was 38 months beginning in January 1995, during which six cardiovascular and seven noncardiovascular fatalities occurred. Coefficient of variation in systolic blood pressure in 1994, as an indicator of systolic blood pressure variability, ranged from 7.8 to 14.6%. Cumulative incidence of death from all causes was related to coefficient of variation in systolic blood pressure. The difference between the maximum and minimum systolic blood pressure (deltaSBP) in 1994 ranged from 44 to 146 mmHg (mean+/-SD, 78+/-13 mmHg) and correlated significantly with coefficient of variation in systolic blood pressure (r = 0.65, P<0.0001). Cox regression analysis was used to identify the independent predictors for mortality. The hazard ratio for death from all causes increased 1.63 times per 1% increase in coefficient of variation in systolic blood pressure (hazard ratio; 95% confidence interval: 1.63; 1.05-2.53) and 1.03 times per 1 mmHg increase in deltaSBP (1.08; 1.03-1.14).
CONCLUSION: These results suggest that systolic blood pressure variability may be a significant prognostic factor in end-stage renal disease.

Entities:  

Mesh:

Year:  1999        PMID: 10462280     DOI: 10.1093/ndt/14.8.1976

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  24 in total

Review 1.  Compelling drug indications in diabetic and nondiabetic nephropathy.

Authors:  Eberhard Ritz; Ralf Dikow; Martin Zeier
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

2.  Blood pressure variability and dialysis: variability may not always be the spice of life.

Authors:  Jennifer E Flythe; Steven M Brunelli
Journal:  J Am Soc Nephrol       Date:  2014-01-02       Impact factor: 10.121

3.  Visit-to-visit blood pressure variability is related to albuminuria variability and progression in patients with type 2 diabetes.

Authors:  S Noshad; M Mousavizadeh; M Mozafari; M Nakhjavani; A Esteghamati
Journal:  J Hum Hypertens       Date:  2013-07-11       Impact factor: 3.012

Review 4.  Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis.

Authors:  Keith M Diaz; Rikki M Tanner; Louise Falzon; Emily B Levitan; Kristi Reynolds; Daichi Shimbo; Paul Muntner
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

Review 5.  Circadian rhythm of blood pressure in renal disease.

Authors:  M Schömig; V Schwenger; E Ritz
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 6.  Does blood pressure variability modulate cardiovascular risk?

Authors:  Peter M Rothwell
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

Review 7.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

8.  Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis.

Authors:  Jennifer E Flythe; Jula K Inrig; Tariq Shafi; Tara I Chang; Kathryn Cape; Kumar Dinesh; Shrikanth Kunaparaju; Steven M Brunelli
Journal:  Am J Kidney Dis       Date:  2013-03-06       Impact factor: 8.860

9.  Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.

Authors:  Tara I Chang; Grace H Tabada; Jingrong Yang; Thida C Tan; Alan S Go
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

Review 10.  Baroreflex contribution to blood pressure and heart rate oscillations: time scales, time-variant characteristics and nonlinearities.

Authors:  M Di Rienzo; G Parati; A Radaelli; P Castiglioni
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2009-04-13       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.